97 related articles for article (PubMed ID: 8330307)
1. Growth of only highly tumorigenic cell lines is inhibited by EAP, a human placental fraction.
Klein JL; Chiodino C; Yamasaki H
Cancer Lett; 1993 Jun; 70(1-2):91-9. PubMed ID: 8330307
[TBL] [Abstract][Full Text] [Related]
2. Growth suppression of transformed cells by a human placental extract not related to transforming growth factor beta.
Klein JL; Hamel E; Tayot JL; Yamasaki H
J Cancer Res Clin Oncol; 1991; 117(3):192-6. PubMed ID: 2033088
[TBL] [Abstract][Full Text] [Related]
3. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
4. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
Serra R; Verderame MF; Isom HC
Cell Growth Differ; 1992 Oct; 3(10):693-704. PubMed ID: 1332741
[TBL] [Abstract][Full Text] [Related]
6. Growth suppression of transformed BALB/c 3T3 cells by transforming growth factor beta 1 occurs only in the presence of their normal counterparts.
Silingardi P; Klein JL; Mesnil M; Yamasaki H
Carcinogenesis; 1994 Jun; 15(6):1181-5. PubMed ID: 8020153
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
8. Transfection of EK-3, a subline of NIH 3T3, with the oncogene Ha-ras does not abolish its anchorage dependence.
Katz E; Samid D
Eur J Cell Biol; 1989 Aug; 49(2):221-4. PubMed ID: 2673787
[TBL] [Abstract][Full Text] [Related]
9. Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene.
Tatsumoto T; Nakano S; Shimizu K; Ono M; Esaki T; Ohshima K; Niho Y
Int J Cancer; 1995 Apr; 61(2):206-13. PubMed ID: 7705949
[TBL] [Abstract][Full Text] [Related]
10. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
11. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
12. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BB.
Bagheri-Yarmand R; Kourbali Y; Morère JF; Jozefonvicz J; Crépin M
Cell Growth Differ; 1998 Jun; 9(6):497-504. PubMed ID: 9663468
[TBL] [Abstract][Full Text] [Related]
14. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection.
Su ZZ; Olsson CA; Zimmer SG; Fisher PB
Anticancer Res; 1992; 12(2):297-304. PubMed ID: 1580547
[TBL] [Abstract][Full Text] [Related]
15. A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene.
Markowitz SD; Myeroff L; Cooper MJ; Traicoff J; Kochera M; Lutterbaugh J; Swiriduk M; Willson JK
J Clin Invest; 1994 Mar; 93(3):1005-13. PubMed ID: 8132740
[TBL] [Abstract][Full Text] [Related]
16. The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells.
Finzi E; Fleming T; Segatto O; Pennington CY; Bringman TS; Derynck R; Aaronson SA
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3733-7. PubMed ID: 3035551
[TBL] [Abstract][Full Text] [Related]
17. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
Braun L; Goyette M; Yaswen P; Thompson NL; Fausto N
Cancer Res; 1987 Aug; 47(15):4116-24. PubMed ID: 2440558
[TBL] [Abstract][Full Text] [Related]
18. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
19. Identification of transformation-related antigen by monoclonal antibody on Swiss 3T3 cells induced by transfection with murine cultured colon 36 tumor DNA.
Sato N; Sato T; Takahashi S; Okubo M; Yagihashi A; Koshiba H; Kikuchi K
J Natl Cancer Inst; 1987 Feb; 78(2):307-13. PubMed ID: 3468294
[TBL] [Abstract][Full Text] [Related]
20. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites.
Ananthaswamy HN; Price JE; Goldberg LH; Bales ES
Cancer Res; 1988 Jun; 48(12):3341-6. PubMed ID: 3370635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]